Physician profile
Mitchell Mccord
NPI 1740849553
$5,387.44
in general payments reported to CMS, 2019-2025
35 companies · $2,059 in 2025
The $2,059 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.86 · 2022: $176 · 2023: $1,134 · 2024: $1,961 · 2025: $2,059.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,154.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,105.02 | 2022-2025 | |
| Novo Nordisk INC | $529.40 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $519.91 | 2023-2025 | |
| Amgen INC. | $472.86 | 2022-2025 | Repatha, Otezla, Repatha |
| Astrazeneca Pharmaceuticals Lp | $335.52 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $310.80 | 2023-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $264.10 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $259.29 | 2023-2025 | |
| Glaxosmithkline, LLC. | $233.73 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Axsome Therapeutics, INC. | $210.22 | 2023-2025 | Auvelity |
| Lilly USA, LLC | $185.67 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $125.33 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.61 | 2024-2025 | Xifaxan, Trulance |
| Corium, LLC | $81.98 | 2023-2025 | Azstarys |
| Bayer Healthcare Pharmaceuticals INC. | $63.19 | 2019-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $61.09 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $55.89 | 2023-2025 | Inspire |
| Mylan Specialty L.P. | $51.46 | 2024 | Yupelri |
| Exact Sciences Corporation | $41.78 | 2023-2025 | Cologuard Collection Kit |
| Pulmonx Corporation | $38.64 | 2023 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Phathom Pharmaceuticals, INC. | $38.11 | 2024-2025 | Voquezna |
| Vanda Pharmaceuticals INC. | $35.06 | 2025 | Fanapt |
| Esperion Therapeutics, INC. | $32.96 | 2024-2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $30.36 | 2022-2025 | Zoryve |
| Janssen Pharmaceuticals, INC | $29.81 | 2024 | Spravato |
| Dynavax Technologies Corporation | $25.02 | 2024-2025 | Heplisav-B |
| Astellas Pharma US INC | $20.39 | 2024 | Veozah |
| Alexion Pharmaceuticals, INC. | $19.54 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.13 | 2024 | Trintellix |
| Celgene Corporation | $18.66 | 2022 | |
| Dexcom, INC. | $18.04 | 2025 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.77 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $17.50 | 2022 | |
| Ardelyx, INC. | $15.35 | 2024 | Ibsrela |
| Hologic Sales and Service, LLC | $14.25 | 2023 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Mccord listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.